1-3 of 3
Balkrishna Jahagirdar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety of Novel Inpatient High Dose Methotrexate Protocol with Reduced Length of Hospital Stay

Wael Toama, Bhaskar Kolla, Jason Hoiness, Peter Hurley, Arkadiusz Dudek, Sally Gustafson, Balkrishna Jahagirdar
Journal: Blood
Blood (2022) 140 (Supplement 1): 5079–5080.
https://doi.org/10.1182/blood-2022-167791
Published: 2022
Journal Articles

Individualized Treatment Summaries and Survivorship Care Plans (SCPs) for Hematopoietic Cell Transplant (HCT) Survivors Reduces Cancer Treatment Distress in a Randomized, Multicenter Study

Navneet S. Majhail, MD MS, Elizabeth Anne Murphy, EdD, Purushottam Laud, MD, Jaime Preussler, MS, Ellen Denzen, MS, Alexia Adams, MPH, RaeAnne Besser, Linda J. Burns, MD, Jan Cerny, Rebecca Drexler, BS, Theresa Hahn, PhD, Lensa Idossa, MPH, Balkrishna Jahagirdar, MBBS, Naynesh Kamani, MD, Alison W. Loren, MD MS, Deborah Mattila, Joseph P. McGuirk, DO, Heather Moore, MPH, Jana Reynolds, MD, Wael Saber, MD MS, Lizette Salazar, Barry Schatz, Patrick J. Stiff, MD, John Wingard, MD, Karen L. Syrjala, PhD, K. Scott Baker, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 331.
https://doi.org/10.1182/blood.V130.Suppl_1.331.331
Published: 2017
Journal Articles

Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma

Steven M. Devine, Balkrishna Jahagirdar, Koen van Besien
Journal: Blood
Blood (2002) 99 (11): 4251–4252.
https://doi.org/10.1182/blood-2002-02-0624
Published: 2002